Computational chemistry approach for the early detection of drug-induced idiosyncratic liver toxicity

Maykel Cruz-Monteagudo1, M Natália D S Cordeiro, Fernanda Borges

  • 1Physico-Chemical Molecular Research Unit, Department of Organic Chemistry, Faculty of Pharmacy, University of Porto, 4150-047 Porto, Portugal.

Insights

Computational models can predict idiosyncratic drug toxicity (IDT), a rare but severe adverse drug reaction. This approach aids early drug discovery by identifying potentially harmful compounds before clinical trials.

Area of Science:

  • * Computational toxicology and cheminformatics.
  • * Drug discovery and development.
  • * Quantitative Structure-Toxicity Relationship (QSTR) modeling.

Background:

  • * Idiosyncratic drug toxicity (IDT) is a host-dependent adverse drug reaction that is difficult to predict during early drug development.
  • * IDT is a rare but serious complication, frequently leading to drug withdrawal or failure to reach the market.
  • * Predicting IDT is crucial for improving drug safety and success rates in pharmaceutical research.

Purpose of the Study:

  • * To systematically evaluate computational classification models for predicting idiosyncratic hepatotoxicity.
  • * To assess the utility of Quantitative Structure-Toxicity Relationship (QSTR) models in early drug discovery for IDT.
  • * To identify computational tools for early prognosis of IDT.

Main Methods:

  • * Development and evaluation of classification models including Linear Discriminant Analysis (LDA), Artificial Neural Networks (ANN), and OneR machine learning algorithm.
  • * Utilized 3D molecular structure representation and feature selection methods to build predictive models.
  • * Internal cross-validation and testing on external datasets to assess model performance and predictivity.

Main Results:

  • * Developed QSTR models with satisfactory internal cross-validation statistics and external predictivity.
  • * Achieved high accuracy (over 84%), sensitivity (over 78%), and specificity (over 90%) in predicting hepatotoxicity.
  • * LDA-based desirability analysis identified key predictor variables for reducing IDT potential.

Conclusions:

  • * The proposed computational approach serves as a valuable tool for early prediction of idiosyncratic drug toxicity.
  • * These QSTR models demonstrate significant potential in identifying drugs with lower risks of IDT during the discovery phase.
  • * The study highlights the importance of computational methods in mitigating drug development risks associated with IDT.

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...